share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股變動聲明-高管 Burnett Patrick
美股SEC公告 ·  11/05 16:51

Moomoo AI 已提取核心訊息

Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 15,441 shares of common stock on November 4, 2024. The transaction was executed in the open market at a price of $8.6842 per share, resulting in a total sale value of approximately $134,092.73. Following the sale, Burnett's direct holdings in the company amount to 179,418 shares of common stock.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 15,441 shares of common stock on November 4, 2024. The transaction was executed in the open market at a price of $8.6842 per share, resulting in a total sale value of approximately $134,092.73. Following the sale, Burnett's direct holdings in the company amount to 179,418 shares of common stock.
Patrick Burnett,與Arcutis生物治療公司[ARQT]相關,於2024年11月4日完成了銷售15,441股普通股的交易。該交易以每股8.6842美元的價格在公開市場上執行,總銷售價值約爲134,092.73美元。此次銷售後,Burnett在該公司的直接持股數量爲179,418股普通股。
Patrick Burnett,與Arcutis生物治療公司[ARQT]相關,於2024年11月4日完成了銷售15,441股普通股的交易。該交易以每股8.6842美元的價格在公開市場上執行,總銷售價值約爲134,092.73美元。此次銷售後,Burnett在該公司的直接持股數量爲179,418股普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息